FDA Adverse Event Injury Summary report: N

RENAL - DISPOSABLE

MDR report key: 1951757 · Received January 6, 2011

Report

Report Number
1423500-2011-00229
Event Type
Injury
Date Received
January 6, 2011
Date of Event
December 1, 2010
Report Date
December 14, 2010
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICES INVOLVED IN THE INCIDENT WERE UNKNOWN. A BATCH REVIEW WILL NOT BE PERFORMED AS THE LOT NUMBER IS UNKNOWN. AS THE DATE OF ONSET OF THIS PERITONITIS EPISODE IS UNKNOWN AND PATIENTS DISCARD SUPPLIES AFTER EACH THERAPY, THE SAMPLE WAS NOT REQUESTED. A 510(K) NUMBER WILL NOT BE PROVIDED IN THE EMDR AS THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED.

Description of Event or Problem · 1

ON AN UNREPORTED DATE, THE PATIENT STARTED TREATMENT WITH DIANEAL PD2 ULTRABAG, (DOSE AND FREQUENCY NOT REPORTED), INTRAPERITONEALLY (IP) FOR PERITONEAL DIALYSIS (PD).ON AN UNKNOWN DATE, A BREAK IN ASEPTIC TECHNIQUE OCCURRED, DESCRIBED AS THE "AREA NOT CLEAN BEFORE STARTING PERITONEAL DIALYSIS." ON (B)(6) 2010, THE PATIENT WAS DIAGNOSED WITH PERITONITIS. ON (B)(6) 2010, THE PATIENT BEGAN REMEDIAL THERAPY WITH VANCOMYCIN (1GM, LOADING DOSE, IP), CEFTAZIDIME (1GM, LOADING DOSE, IP), CEFTAZIDIME (250MG, CONTINUING, IP), AMIKACIN (100MG, DAILY, IP) AND HEPARIN (2000 UNITS, CONTINUING, IP). DIANEAL THERAPY WAS ONGOING. IT WAS NOT REPORTED WHETHER THE PATIENT WAS RETRAINED; THEREFORE THE OUTCOME FOR THE EVENT OF OF BREAK IN ASEPTIC TECHNIQUE WAS UNKNOWN. THE REPORTER BELIEVED THAT THE PERITONITIS WAS NOT RELATED TO THE DIANEAL THERAPY, BUT WAS DUE TO THE BREAK IN ASEPTIC TECHNIQUE. A CAUSALITY STATEMENT WAS NOT REPORTED FOR THE BREAK IN ASEPTIC TECHNIQUE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RENAL - DISPOSABLE SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ

Patients

Seq Age Sex Outcome Treatment
1 54 YR Required Intervention DIANEAL PD2 ULTRABAG